• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

STAT3 的激活是对白细胞介素-6(IL-6)反应的一种表现,这种激活可通过白细胞介素-6 受体(IL-6R)与表皮生长因子受体(EGF receptor)的结合而延长。

STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor.

机构信息

School of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, People's Republic of China.

出版信息

Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16975-80. doi: 10.1073/pnas.1315862110. Epub 2013 Sep 30.

DOI:10.1073/pnas.1315862110
PMID:24082147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3801081/
Abstract

The activation of STAT3 by tyrosine phosphorylation, essential for normal development and for a normal inflammatory response to invading pathogens, is kept in check by negative regulators. Abnormal constitutive activation of STAT3, which contributes to the pathology of cancer and to chronic inflammatory diseases such as rheumatoid arthritis, occurs when negative regulation is not fully effective. SOCS3, the major negative regulator of STAT3, is induced by tyrosine-phosphorylated STAT3 and terminates STAT3 phosphorylation about 2 h after initial exposure of cells to members of the IL-6 family of cytokines by binding cooperatively to the common receptor subunit gp130 and JAKs 1 and 2. We show here that when the epidermal growth factor receptor (EGFR) is present and active, STAT3 is rephosphorylated about 4 h after exposure of cells to IL-6 or oncostatin M and remains active for many hours. Newly synthesized IL-6 drives association of the IL-6 receptor and gp130 with EGFR, leading to EGFR-dependent rephosphorylation of STAT3, which is not inhibited by the continued presence of SOCS3. This second wave of STAT3 activation supports sustained expression of a subset of IL-6-induced proteins, several of which play important roles in inflammation and cancer, in which both IL-6 secretion and EGFR levels are often elevated.

摘要

STAT3 的酪氨酸磷酸化激活对于正常发育和对入侵病原体的正常炎症反应至关重要,但它受到负调控因子的控制。STAT3 的异常持续激活导致癌症和慢性炎症性疾病(如类风湿关节炎)的病理发生,这种异常持续激活发生在负调控不完全有效的情况下。SOCS3 是 STAT3 的主要负调控因子,它被酪氨酸磷酸化的 STAT3 诱导,并在细胞最初暴露于白细胞介素-6 家族细胞因子后的大约 2 小时与共同受体亚基 gp130 和 JAKs1 和 2 协同结合,终止 STAT3 的磷酸化。我们在这里表明,当表皮生长因子受体 (EGFR) 存在并活跃时,细胞暴露于白细胞介素-6 或肿瘤坏死因子-α后大约 4 小时,STAT3 会重新磷酸化,并持续活跃数小时。新合成的白细胞介素-6 驱动白细胞介素-6 受体和 gp130 与 EGFR 结合,导致 EGFR 依赖性 STAT3 重新磷酸化,这不受 SOCS3 持续存在的抑制。这第二波 STAT3 激活支持白细胞介素-6 诱导的蛋白质的一部分的持续表达,其中一些在炎症和癌症中发挥重要作用,在这些疾病中,白细胞介素-6 的分泌和 EGFR 水平通常升高。

相似文献

1
STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor.STAT3 的激活是对白细胞介素-6(IL-6)反应的一种表现,这种激活可通过白细胞介素-6 受体(IL-6R)与表皮生长因子受体(EGF receptor)的结合而延长。
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16975-80. doi: 10.1073/pnas.1315862110. Epub 2013 Sep 30.
2
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.表皮生长因子受体(EGFR)激酶结构域中的突变通过在人肺腺癌中产生白细胞介素-6(IL-6)来介导信号转导和转录激活因子3(STAT3)的激活。
J Clin Invest. 2007 Dec;117(12):3846-56. doi: 10.1172/JCI31871.
3
Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.抑瘤素M受体介导的信号转导通过一种不依赖受体酪氨酸的机制被细胞因子信号转导抑制因子3负调控。
J Biol Chem. 2006 Mar 31;281(13):8458-68. doi: 10.1074/jbc.M511212200. Epub 2006 Feb 2.
4
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.STAT3是体内白细胞介素-6-糖蛋白130依赖性铁调素激活所必需的。
Gastroenterology. 2007 Jan;132(1):294-300. doi: 10.1053/j.gastro.2006.10.018. Epub 2006 Oct 17.
5
The tyrosine phosphatase SHP2 increases robustness and information transfer within IL-6-induced JAK/STAT signalling.酪氨酸磷酸酶 SHP2 增加了 IL-6 诱导的 JAK/STAT 信号转导中的鲁棒性和信息传递。
Cell Commun Signal. 2021 Sep 16;19(1):94. doi: 10.1186/s12964-021-00770-7.
6
Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.类黄酮诱导细胞因子信号转导抑制因子 3(SOCS3)基因的表达,并抑制血管内皮细胞中白细胞介素 6 激活的信号转导子和转录激活子 3(STAT3)的激活。
Biochem J. 2013 Sep 1;454(2):283-93. doi: 10.1042/BJ20130481.
7
Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.在头颈部鳞状细胞癌中,SOCS-1的表观遗传修饰通过JAK和/或MEK对白细胞介素-6受体和表皮生长因子受体信号作出反应,差异性地调节STAT3激活。
Mol Cancer Ther. 2006 Jan;5(1):8-19. doi: 10.1158/1535-7163.MCT-05-0069.
8
Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.白细胞介素6抑制增殖,并与表皮生长因子受体自分泌环协同作用,增加T47D乳腺癌细胞的迁移。
Cancer Res. 2001 Jan 1;61(1):383-91.
9
Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.白血病抑制因子(LIF)和抑瘤素M(OSM)对人颗粒细胞系COV434中JAK/STAT信号通路的刺激作用
J Reprod Immunol. 2015 Apr;108:48-55. doi: 10.1016/j.jri.2015.03.002. Epub 2015 Mar 16.
10
Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.脓毒症诱导白细胞介素 6、gp130/JAK2/STAT3 和肌肉减少症。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):713-727. doi: 10.1002/jcsm.12867. Epub 2021 Nov 24.

引用本文的文献

1
Current Mechanobiological Pathways and Therapies Driving Spinal Health.驱动脊柱健康的当前机械生物学途径与疗法
Bioengineering (Basel). 2025 Aug 20;12(8):886. doi: 10.3390/bioengineering12080886.
2
Different Master Regulators Define Proximal and Distal Gastric Cancer: Insights into Prognosis and Opportunities for Targeted Therapy.不同的主调控因子界定近端和远端胃癌:对预后的见解及靶向治疗机会
Curr Oncol. 2025 Jul 28;32(8):424. doi: 10.3390/curroncol32080424.
3
The mechanism of action of micafungin against pteropine orthoreovirus infection in the human A549 cell line.米卡芬净对人A549细胞系中翼手目正呼肠孤病毒感染的作用机制。
Arch Virol. 2025 Aug 25;170(9):201. doi: 10.1007/s00705-025-06369-4.
4
Glucose Metabolism Sustains Aberrant STAT3 Signaling in Colorectal Cancer via Glycosylated Paracrine Factors.葡萄糖代谢通过糖基化旁分泌因子维持结直肠癌中异常的STAT3信号传导。
bioRxiv. 2025 Jul 26:2025.07.22.666143. doi: 10.1101/2025.07.22.666143.
5
Unraveling the role of STAT3 in Cancer Cachexia: pathogenic mechanisms and therapeutic opportunities.解析信号转导和转录激活因子3(STAT3)在癌症恶病质中的作用:致病机制与治疗机遇
Front Endocrinol (Lausanne). 2025 Jul 9;16:1608612. doi: 10.3389/fendo.2025.1608612. eCollection 2025.
6
Anti-Neoplastic Activity of Estrogen Receptor Beta in Chemoresistant Triple-Negative Breast Cancer.雌激素受体β在化疗耐药三阴性乳腺癌中的抗肿瘤活性
Cancers (Basel). 2025 Jun 25;17(13):2132. doi: 10.3390/cancers17132132.
7
The Significance of STAT3 in Colonic Diseases: A Comprehensive Study of Pathological Roles and Therapeutic Implications.STAT3在结肠疾病中的意义:病理作用与治疗意义的综合研究
Cell Biochem Biophys. 2025 Jul 8. doi: 10.1007/s12013-025-01816-0.
8
Recent research advances in interleukin, microRNA and neuroendocrine tumor biomarkers (Review).白细胞介素、微小RNA与神经内分泌肿瘤生物标志物的最新研究进展(综述)
Mol Clin Oncol. 2025 Jun 17;23(2):71. doi: 10.3892/mco.2025.2866. eCollection 2025 Aug.
9
Fibroblast EGFR signaling mediates ricin toxin-induced acute lung injury via EGR1/CXCL1 axis.成纤维细胞表皮生长因子受体信号通过EGR1/CXCL1轴介导蓖麻毒素诱导的急性肺损伤。
Arch Toxicol. 2025 May 3. doi: 10.1007/s00204-025-04067-3.
10
Role of mitogens in normal and pathological liver regeneration.有丝分裂原在正常及病理性肝再生中的作用。
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000692. eCollection 2025 May 1.

本文引用的文献

1
A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo.从 STAT3 到 OCT4-NANOG 回路的遗传和发育途径对于体内 ICM 谱系的维持是必不可少的。
Genes Dev. 2013 Jun 15;27(12):1378-90. doi: 10.1101/gad.221176.113.
2
SOCS3 binds specific receptor-JAK complexes to control cytokine signaling by direct kinase inhibition.SOCS3 通过直接抑制激酶与特定的受体-JAK 复合物结合来控制细胞因子信号。
Nat Struct Mol Biol. 2013 Apr;20(4):469-76. doi: 10.1038/nsmb.2519. Epub 2013 Mar 3.
3
Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.靶向 Stat3 可消除癌症中 EGFR 抑制剂耐药性。
Clin Cancer Res. 2012 Sep 15;18(18):4986-96. doi: 10.1158/1078-0432.CCR-12-0792. Epub 2012 Jul 23.
4
Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.针对乳腺癌和肺癌中的多药耐药性:从耐药逆转研究的失败中辨别其潜在重要性。
Drug Resist Updat. 2012 Feb-Apr;15(1-2):50-61. doi: 10.1016/j.drup.2012.02.002. Epub 2012 Mar 29.
5
Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.人类癌症中 EGFR 信号网络的全景:与受体亚细胞定位相关的生物学和治疗反应。
Cancer Lett. 2012 May 28;318(2):124-34. doi: 10.1016/j.canlet.2012.01.011. Epub 2012 Jan 17.
6
Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.配体依赖性 EGFR 激活通过 NFkB 通路诱导晚期上皮性卵巢癌中 IL-6 和 PAI-1 的共表达。
Oncogene. 2012 Sep 13;31(37):4139-49. doi: 10.1038/onc.2011.572. Epub 2011 Dec 12.
7
The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis.白细胞介素-6的多面性:白细胞介素-6在系统性硬化症的炎症、血管病变和纤维化中的作用
Int J Rheumatol. 2011;2011:721608. doi: 10.1155/2011/721608. Epub 2011 Sep 20.
8
Deactivation of signal transducer and activator of transcription 3 reverses chemotherapeutics resistance of leukemia cells via down-regulating P-gp.信号转导子和转录激活子 3 的失活通过下调 P-糖蛋白逆转白血病细胞的化疗耐药性。
PLoS One. 2011;6(6):e20965. doi: 10.1371/journal.pone.0020965. Epub 2011 Jun 6.
9
AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis.AMPK 激动剂下调 TNBS 诱导的小鼠急性和复发性结肠炎中的固有和适应性免疫反应。
Biochem Pharmacol. 2010 Dec 1;80(11):1708-17. doi: 10.1016/j.bcp.2010.08.009. Epub 2010 Aug 24.
10
STATs in cancer inflammation and immunity: a leading role for STAT3.信号转导和转录激活因子在癌症炎症与免疫中的作用:信号转导和转录激活因子3起主导作用
Nat Rev Cancer. 2009 Nov;9(11):798-809. doi: 10.1038/nrc2734.